Trade JnJ ^JNJ

Hamlin Capital Management LLC Sells 4,916 Shares of Johnson & Johnson $JNJ

Plan A Wealth LLC Raises Position in Johnson & Johnson $JNJ

Apella Capital LLC Boosts Position in Johnson & Johnson $JNJ

Toth Financial Advisory Corp Sells 2,196 Shares of Johnson & Johnson $JNJ - Zolmax

Learn Why The Bull Case For Intuitive Surgical Stock Could Change Following Barclays Coverage

Johnson & Johnson $JNJ Shares Sold by Gradient Investments LLC - Stock Observer

2,196 Johnson & Johnson $JNJ Shares Sold by Toth Financial Advisory Corp - Daily Political

Congress Asset Management Co. Boosts Stake in Johnson & Johnson $JNJ

Amgen (AMGN) and Johnson & Johnson (JNJ) Catch Jim Cramer's Eye for Different Reasons

Menopause and musculoskeletal health: a call to action

3 'Strong Buy' Dividend Aristocrat Stocks on Analysts' Watch List

How's the stock market doing, minus AI?

Intuitive Surgical (ISRG) and JNJ Give Jim Cramer More Than Valuation to Consider

Pfizer (PFE) Trades Below 10x Earnings. Why Does Johnson & Johnson (JNJ) Command More Than Twice the Multiple?

Johnson & Johnson (JNJ) Is Becoming a Growth Stock. Does AbbVie (ABBV) Make JNJ Look Expensive?

What Q3 earnings might bring next week

Moderna, Eli Lilly Lead Healthcare Stocks Higher on a Down Day for Markets

Johnson & Johnson $JNJ Holdings Trimmed by American National Bank & Trust - Markets Daily

Johnson & Johnson $JNJ Shares Purchased by Cooper Financial Group - Daily Political

Canandaigua National Trust Co of Florida Makes New Investment in Johnson & Johnson $JNJ - Daily Political

Does Long Term Psoriasis Data Change The Bull Case For Johnson & Johnson Stock (JNJ)? - Simply Wall St News

Johnson & Johnson Has Dividend Royalty Status. Does That Make It a Buy?

Johnson & Johnson (NYSE:JNJ) Stock Rating Reaffirmed as Buy by Guggenheim

American National Bank & Trust Sells 4,125 Shares of Johnson & Johnson $JNJ - Stock Observer

The Crash-Proof Portfolio: 5 Elite Dividend Stocks Built to Survive a Market Meltdown

Jim Cramer Has Soured on Intuitive Surgical (ISRG). The Reason is Johnson & Johnson

Johnson & Johnson $JNJ Stock Holdings Cut by Hall Laurie J Trustee - Markets Daily

Portal Innovations and the New Brunswick Development Corporation Celebrate Grand Opening of the New Jersey Innovation Hub with Ribbon Cutting Ceremony | Morningstar

5,446 Shares in Johnson & Johnson $JNJ Bought by Eleva Capital SAS - Zolmax

Johnson & Johnson $JNJ Shares Newly Purchased by Eleva Capital SAS

Johnson & Johnson $JNJ Stock Bought by Colton Groome Financial Advisors LLC

Procter & Gamble Has Raised Its Dividend for 70 Years. These 4 Stocks Share Its Reliability

Johnson & Johnson or Procter & Gamble: If I Could Only Own 1 Dividend King for 20 Years, This Is It - 24/7 Wall St.

Johnson & Johnson $JNJ Shares Sold by Iowa State Bank - Daily Political

Johnson & Johnson (JNJ) Expected to Post Quarterly Earnings on Tuesday

Johnson & Johnson (NYSE:JNJ) Stock Falls 1.2% - What's Next?

Top Pharmaceutical Stocks To Follow Now - October 5th - Markets Daily

Johnson & Johnson $JNJ Stake Trimmed by Park National Corp OH

Johnson & Johnson $JNJ Shares Acquired by Ferguson Wellman Capital Management Inc.

Eastern Bank Boosts Stock Holdings in Johnson & Johnson $JNJ

Johnson & Johnson $JNJ Shares Sold by Argent Capital Management LLC

Top Pharmaceutical Stocks To Follow Now - October 5th - Stock Observer

Johnson & Johnson (NYSE:JNJ) Shares Down 1.2% - Should You Sell? - Daily Political

4,125 Johnson & Johnson $JNJ Shares Sold by Rockland Trust Co. - Daily Political

MassMutual Private Wealth & Trust FSB Sells 7,399 Shares of Johnson & Johnson $JNJ

Best Pharmaceutical Stocks To Add to Your Watchlist - October 4th - Stock Observer

Is Buying Nike Stock Now a Brilliant Move or a Disaster Waiting to Happen? Here's the Answer and What to Do Next. - AOL

What is Linde's (LIN) Economic Moat, and is it Widening or Narrowing?

Municipal Bonds vs Dividend Stocks: Which Income Actually Keeps More of Your Money?

Johnson & Johnson (NYSE:JNJ) Stock Now Rated "Moderate Buy" by Sell-Side Analysts - Daily Political

Pharmaceutical Stocks To Watch Now - October 3rd - Zolmax

Wells Fargo Sticks to Its Buy Rating for AxoGen (AXGN)

Eli Lilly (LLY) and AbbVie (ABBV) Are Expanding Their Pipelines. Their Valuations Tell Two Different Stories

CX Institutional Grows Holdings in Johnson & Johnson $JNJ

Johnson & Johnson (NYSE:JNJ) Shares Down 1.1% - Here's What Happened

Analyzing Johnson & Johnson (NYSE:JNJ) and Rafael (NYSE:RFL)

Johnson & Johnson (JNJ) Stock: Rebounds as ICOTYDE Delivers Strong Two-Year Psoriasis Results

Johnson & Johnson Presents New Data Validating ICOTYDE In Treatment Of Psoriasis

Johnson & Johnson announces new ICOTYDE® (icotrokinra) data in difficult-to-treat plaque psoriasis with proven durability through 2-years, affirming its use as a powerful first line systemic therapy | Morningstar

Financial Contrast: Rafael (NYSE:RFL) vs. Johnson & Johnson (NYSE:JNJ) - Stock Observer

BofA thinks Wall Street is underestimating one J&J drug

Coastline Trust Co Decreases Stock Holdings in Johnson & Johnson $JNJ

Best Pharmaceutical Stocks To Follow Today - October 1st - Stock Observer

2,182 Johnson & Johnson $JNJ Shares Sold by Coastline Trust Co - Stock Observer

History Says Johnson & Johnson Beats Medtronic. Here's Why I'd Still Consider MDT for the Next Decade.

5 High-Yield Dividend Stocks That Pass the Coverage Test (Not Just the Yield Test)

Johnson & Johnson (JNJ) Stock Could Be Undervalued On Future Cash Flow - Simply Wall St News

What is Johnson & Johnson's (JNJ) Economic Moat, and is it Widening or Narrowing?

PepsiCo (PEP) Taps A Healthcare Chief For Its Board At A Key Moment

Promising Pharmaceutical Stocks Worth Watching - September 30th

Johnson & Johnson (JNJ) Shares In Focus After New Adolescent gMG Data

Vascular Dementia Market to Expand Rapidly with Advancing Pipeline and Increasing Treatment Adoption by 2034 - DelveInsight | Pfizer, Gilead Sciences, ViiV Healthcare | ABNewswire

Sugar-rich foods exacerbate antibiotic-induced microbiome disruption

Johnson & Johnson (NYSE:JNJ) Stock Price Down 1.6% - Here's Why

JPMorgan Chase & Co. Forecasts Strong Price Appreciation for Johnson & Johnson (NYSE:JNJ) Stock

J&J's IMAAVY Shows Sustained Disease Control In New GMG Data

Living Off Dividends at 65: 3 Stocks That Raised Payouts for Longer Than 30 Years

Johnson & Johnson (JNJ) Stock May Be Undervalued As Its 96% Run Continues

Johnson & Johnson (NYSE:JNJ) Stock Has Average Target Price of $274.13 According to Analysts

How Investors Are Reacting To Apollo Global Management Stock Private Credit Concerns

Best Pharmaceutical Stocks To Follow Now - September 26th - Daily Political

Sjogren's Syndrome Market Poised for Sustained Growth Amid Advancements in Treatment and Clinical Innovation by 2036 - DelveInsight | Astellas Pharma, Immunovant Sciences, NK Cells Artiva Biotherap | ABNewswire

Is Johnson & Johnson (JNJ) Building a Stronger Post-Stelara Growth Story?

Chubb Insurance Units Sued Over Coverage for Talc Injury Cases

Promising Pharmaceutical Stocks To Research - September 28th - Zolmax

Can J&J's Latest Trial Win Strengthen its Neuroscience Business? - Insider Monkey

Johnson & Johnson's Next Growth Engine Is Taking Shape

Healthcare Stocks To Add to Your Watchlist - September 28th - Zolmax

ETFs Are Net Sellers of Johnson & Johnson (JNJ) on Sept. 24

Johnson & Johnson Unveils 3 Consecutive New Innovations: Ushering Fracture Treatment into the Fully Automatic Mode Era